BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 12094376)

  • 1. Prognostic significance of atypical papillary urothelial hyperplasia.
    Swierczynski SL; Epstein JI
    Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
    Cina SJ; Lancaster-Weiss KJ; Lecksell K; Epstein JI
    Arch Pathol Lab Med; 2001 May; 125(5):646-51. PubMed ID: 11300936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial papilloma of the bladder: a review of 34 de novo cases.
    Magi-Galluzzi C; Epstein JI
    Am J Surg Pathol; 2004 Dec; 28(12):1615-20. PubMed ID: 15577681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypia in inverted urothelial papillomas: pathology and prognostic significance.
    Broussard JN; Tan PH; Epstein JI
    Hum Pathol; 2004 Dec; 35(12):1499-504. PubMed ID: 15619209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary urothelial hyperplasia. A precursor to papillary neoplasms.
    Taylor DC; Bhagavan BS; Larsen MP; Cox JA; Epstein JI
    Am J Surg Pathol; 1996 Dec; 20(12):1481-8. PubMed ID: 8944041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of the urothelial tumors of the urinary bladder.
    Helpap B; Köllermann J
    Hum Pathol; 2000 Jun; 31(6):745-50. PubMed ID: 10872670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary urothelial hyperplasia: relationship to urothelial neoplasms.
    Readal N; Epstein JI
    Pathology; 2010 Jun; 42(4):360-3. PubMed ID: 20438409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
    Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
    J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder.
    Sun W; Zhang PL; Herrera GA
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):327-31. PubMed ID: 12607601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
    Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
    Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.
    Nguyen JK; Przybycin CG; McKenney JK; Magi-Galluzzi C
    Hum Pathol; 2020 Apr; 98():81-88. PubMed ID: 32142835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.
    McKenney JK; Gomez JA; Desai S; Lee MW; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):356-62. PubMed ID: 11224606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Next-Generation Sequencing of Flat Urothelial Lesions Reveals Putative Pathobiological Pathways, Potential Biomarkers, and Rational Therapeutic Targets.
    Musangile FY; Matsuzaki I; Iwamoto R; Sagan K; Nishikawa M; Mikasa Y; Takahashi Y; Kojima F; Hara I; Murata SI
    Mod Pathol; 2023 May; 36(5):100120. PubMed ID: 36812689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concept of schistosomiasis lesions of urinary bladder versus development of bladder cancer.
    Sabe I; Mangoud AM; Elalfy Y; Elsayed M; Shaaban W; Hafez AO; El Sherbini GT; Morsy AT
    J Egypt Soc Parasitol; 2008 Apr; 38(1):85-102. PubMed ID: 19143123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
    Kryvenko ON; Epstein JI
    J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.